Do you think the larger pharma companies will look to buy out the smaller biotech companies?
Not only in the drug business, but all over, the larger companies are trying to find the new, innovative, profitable companies and bring them into the fold. The new companies need money, the old companies need a jolt of fresh profits, and usually these takeovers happen quickly. For investors, I suggest staying away from the very large companies, because they have so many shares of stock trading that it takes a lot of volume to push up the price. The best gains are in companies that are trading less than 100 million shares. Q: Would you be buying Pfizer (PFE ) now? A: I would wait and not buy the big drug company stocks until the market has stabilized. We probably have another two months to go, but I would not put money in the big drug companies right now. Q: Pat, what investment strategy would you recommend for the current market, assuming a fairly long horizon? A: I think investors should be looking at stocks that will continue to be in demand, and that means companies dealing with li